Pontin Acts as a Potential Biomarker for Poor Clinical Outcome and Promotes Tumor Invasion in Hilar Cholangiocarcinoma

Table 2

Univariate analysis of clinicopathological features for OS of 86 patients with hilar cholangiocarcinoma.

Characteristics		Survival rate (%)
Gender			0.544
Male	54	38.9
Female	32	46.9
Age (years)			0.497
<60	41	46.3
≥60	45	37.8
Differentiation			0.021
Well/moderately	51	52.9
Poorly	35	25.7
Bismuth–Corlette classification			0.357
Type I	22	40.9
Type II	11	45.5
Type IIIa	12	41.7
Type IIIb	15	46.7
Type IV	26	38.5
Tumor size (cm)			0.299
<3	31	41.9
3–5	19	47.3
≥5	36	38.9
Tumor stage			0.316
T1	20	45.0
T2	27	48.1
T3	39	35.9
Lymph node metastasis			0.011
No	59	47.5
Yes	27	29.6
TNM stage			0.044
I	23	56.5
II	20	45.0
IIIa	16	31.2
IIIb	27	29.6
Pontin expression			0.002
Low	52	50.0
High	34	29.4

; .